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True aneurysm formation in arterialized autologous veins is an unusual complication.
We studied a patient with 2 aneurysms occurring in the mid and distal portion of an in
situ femoropopliteal bypass. The first aneurysm led to graft occlusion 4 years after the
primary intervention, requiring replacement of the ectatic graft segment. The graft was
still patent when the patient was examined 7 years after the primary intervention and 3
years after the first aneurysm. In the mid portion of the graft, a true aneurysm measur-
ing 5 by 8 cm had developed. The aneurysm was replaced by a reversed segment of the
contralateral greater saphenous vein. Recovery was uneventful. Advanced atherosclerot-
ic changes with extensive intimal fibroplasia, subendothelial cholesterol deposits, and
ulcerations were revealed by means of histopathology of the aneurysm wall.
Atherosclerosis is considered to be the main cause of aneurysm formation in vein grafts,
but a review of the literature suggests the additional etiopathogenic factors should be
further investigated. (J Vasc Surg 1998;28:944-8.)
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True aneurysm formation within arterialized
saphenous vein grafts is an unusual complication of
bypass graft surgery. Davidson first described this
entity in 1972.1 In 1973, Szilagyi2 reported on the
biologic fate of saphenous vein grafts in 260 patients.
Atherosclerotic degeneration was found in a third of
the patients, but graft aneurysms were found in only
10 patients. Atherosclerosis in the graft was associat-
ed with hyperlipidemia and arterial hypertension.
Cardiovascular risk factors did not correlate with
graft aneurysms.3-6 The cause of vein graft aneurysms
is still unclear; atherosclerosis is thought to be one of
the main factors in their development.7
We studied a patient with 2 true aneurysms in the
mid and distal portion of an in situ femoropopliteal
bypass graft, which had been implanted 7 years earli-
er for the treatment of a thrombosed popliteal artery
aneurysm. Pertinent literature is reviewed and partic-
ular attention is given to the etiopathogenic factors
involved in this disorder and its clinical consequences.
CASE REPORT
Seven years ago, a 55-year-old man came to our insti-
tution with an acute thrombosed right popliteal aneurysm.
An in situ saphenous vein graft was implanted. His past
medical history was remarkable for longstanding arterial
hypertension and heavy cigarette smoking. The patient had
no diabetes mellitus, and his cholesterol and triglyceride
levels were normal. Three years after the first intervention,
he had a sudden onset of resting right leg pain, and graft
thrombosis was revealed by means of angiography. The
patient underwent thrombectomy and thrombolysis, which
resulted in complete recanalization. In the graft, a true
aneurysm 4 cm proximal of the anastomosis to the
popliteal artery had developed. The aneurysmatic segment
was replaced by a reversed saphenous vein from the con-
tralateral side, requiring a new anastomosis to the tibioper-
oneal trunk. Recovery was uneventful, but the patient con-
tinued smoking. Four years later, the patient noted a grow-
ing pulsatile mass in his right thigh. Within 4 weeks, the
mass expanded rapidly, causing extreme discomfort
because of tension on the overlying skin. Dilatation of the
in situ portion of the graft and an aneurysm measuring 5
cm in transverse diameter and extending over 8 cm at the
level of the midthigh were disclosed by means of color
duplex Doppler ultrasound scan and magnetic resonance
(MR) angiography (Fig 1). The ectatic portion of the graft
was replaced by a reversed segment of greater saphenous
vein (Fig 2). Recovery was uneventful, and the patient was
included in a follow-up program with regular graft map-
ping by means of color duplex Doppler ultrasound scan
every 6 months. After 1 year of follow-up, the graft
remained patent and had no signs of dilatation.
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By means of histopathologic examination of the
explanted aneurysm, it was revealed that the structural
architecture of the vessel wall was obliterated by invading
atherosclerotic plaques (Fig 3). Extensive intimal fibropla-
sia was noted, and the thickened intima was altered by
hemorrhage and cholesterol deposits with ulceration and
focal thrombi. A specimen of excised aneurysmal vein
bypass graft was sent for microbiological examination.
Cultures were negative for gram-positive, gram-negative,
and anaerobic organisms and for fungi and mycobacteria.
DISCUSSION
The autologous saphenous vein represents the
conduit of choice for revascularization of the lower
extremity. Histopathologic changes in the vein grafts
have been well known since the initial development of
this technique. Endothelial disruption and suben-
dothelial transformation, such as medial necrosis, loss
of elastic elements, and fibrous proliferation, are the
main findings.8 Long-term follow-up studies lasting
up to 10 years showed severe atherosclerotic degener-
ation of the grafts, frequently associated with hyper-
lipidemia and arterial hypertension.3-4 These changes
were found in one third of the explanted veins used
for femoropopliteal reconstruction.2 In saphenous
vein grafts used for coronary artery bypass grafting,
marked atherosclerotic changes were observed in
more than 50% of conduits.9 Manipulation of the vein
during harvest may cause loss of endothelial integrity,
with subsequent increase in cellular proliferation and
lipid infiltration.10 It was postulated that the use of in
situ grafting could reduce atherosclerotic degenera-
tion of the vein,11 but follow-up studies showed that
long-term patency rates are similar for both reversed
and in situ saphenous grafts.12-13
In contrast to denatured venous homografts,14
true aneurysm formation in arterialized autologous
veins is an unusual occurrence. Szilagyi2 found 10
venous aneurysms in 377 operated legs, but none
required surgical reintervention. The world litera-
ture on infrainguinal nonanastomotic aneurysms in
vein grafts is summarized in Table I. Clinical mani-
festation is mostly characterized by a pulsatile mass,
which may lead to skin ulceration, acute rupture,
graft thrombosis, or distal embolization. According
to the literature, the mean time from graft implanta-
tion to clinical manifestation of the aneurysm is 7
years, but graft dilatation was observed as early 
as 2 years postoperatively.15 DeWeese16 reported
aneurysm formation 1 year after graft implantation
with a postoperative recurrence 5 months later, but
infection rather than atherosclerosis was suspected
to be the cause of early aneurysms. In our case, the
first aneurysm developed 3 years after in situ graft-
ing, and it was corrected with a venous interposi-
tion. The same procedure was used 4 years later
when a second aneurysm formed in the original por-
tion of the graft. A short-segment of the anterior
tibial artery was shown by means of MR angiogra-
phy to be the only runoff vessel in the calf. This is a
common occurrence in patients with long-standing
femoro-popliteal aneurysm, because this represents a
source of recurrent emboli leading to chronic occlu-
sion of calf vessels. The choice of a vein rather than
of a prosthetic conduit to repair graft aneurysm in
this young patient was dictated (1) by the higher
long-term patency rate of autologous material for
below-knee reconstruction, especially if there are
poor runoff vessels; (2) because it was not possible
at surgery to exclude a low-grade mycotic aneurysm,
and therefore, the implantation of an autologous
graft was preferred; (3) by the positive experience
with the distal part of the graft, which had been
replaced 4 years earlier with a reversed segment of
the left greater saphenous vein and was still patent
and not dilatated.
The etiology of venous graft aneurysms remains
unclear; however, some factors have been proposed as
Fig 1. Dilatation of the entire in situ graft and a 5 cm
measuring graft aneurysm extending over 8 cm at the level
of the right midthigh disclosed by means of coronal refor-
matted 3D-time-of-flight magnetic resonance angiogram.
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at least partly responsible for this long-term complica-
tion after bypass graft surgery. In a number of graft
aneurysms reported (Table I), the bypass graft has
been performed to repair a popliteal artery aneurysm,
and concomitant abdominal aortic aneurysm was a
frequent finding. This suggests a generalized propen-
sity of aneurysms to develop both in arteries and arte-
rialized veins in some patients. Advanced atheroscle-
rotic changes with extensive intimal fibroplasia,
subendothelial cholesterol deposits, and ulcerations
Fig 3. A, Nonaneurysmal segment of the explanted arteriosclerotic bypass graft showing 
B, arteriosclerotic plaque with medial fibrosis (original magnification, 60· ; hematoxylin and
eosin). C, Aneurysmal segment with cholesterol deposits (original magnification, 40· ; hema-
toxylin and eosin), and D, intimal fibroplasia (original magnification, 40· ; Elastin van Gieson).
Fig 2. Intraoperative situs showing the exposed aneurysm.
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were disclosed by means of histopathologic examina-
tion of the aneurysm. These micromorphologic
changes cause weakening of the vascular wall, espe-
cially because of penetrating atherosclerotic plaques
with subsequent mural destruction, and, therefore,
atherosclerosis is considered to be the main cause for
aneurysm formation in arterialized vein grafts.7
Atherosclerosis affects approximately 30% to 50%
of arterialized veins, but true graft aneurysms repre-
sent an unusual complication. Therefore, additional
etiologic factors leading to graft aneurysm should be
considered. 
A poststenotic dilatation has been proved to be
responsible for the development of aneurysms
(hemodynamic origin). A poststenotic dilatation
becomes a true aneurysm when the diameter criteri-
on is met and the ectasia becomes permanent and
fixed. Classic examples are cervical rib and impinge-
ment on peripheral arteries (eg, popliteal entrap-
ment). Similarly, a stenotic segment in the vein graft
(eg, valvular stenosis or postphlebitic) or a graft
impingement could produce a poststenotic dilata-
tion with subsequent development of an aneurysm.
Vessel dilatation causes boundary layer separation
along the intimal surface, and hemodynamic forces
stimulate subintimal proliferative changes resulting
in plaque formation.17 This is supported by the evi-
dence that arteriosclerotic changes also occur in
poststenotic aneurysms. 
Graft aneurysms can develop from a low-grade
graft infection (mycotic aneurysm). Cultures of an
excised specimen of the aneurysm were negative, but
infections with slowly growing microorganisms,
such as Staphylococcus epidermidis, are difficult to
detect. In prosthetic graft infections, mechanical dis-
ruption of the bacteria from the graft surface, either
by means of tissue grinding or ultrasonic disruption,
and culture in broth media increase the identifica-
tion of bacteria compared with routine culture
methods.18 The efficacy of this method, however,
for venous grafts was not proved. 
There is evidence of excessive tobacco consump-
tion in most patients with graft aneurysms. Tobacco
is a risk factor for accelerated atherosclerosis, but the
role of nicotine as an independent predictor of
abdominal aortic aneurysm is debated because nico-
tine plays an active role in the development of vas-
cular disease by inducing neutrophils to release elas-
tase activity.19 A similar mechanism on vein grafts
has not been investigated yet.
The management of vein graft aneurysm is subject
to the same criteria that apply to other aneurysms,
and surgical repair is indicated. According to the liter-
ature reviewed and in our personal observation, graft
dilatation occurs in several months and is followed by
a rapid increase in size within a few weeks, leading to
pain, skin tension, and possible rupture. Therefore,
graft aneurysms, once diagnosed, should be repaired
as soon as possible. In the presence of a diffuse dilata-
tion, the entire graft should be replaced. If there is
evidence of an isolated aneurysm, the graft can be pre-
served and the aneurysm replaced with autologous or
Table I. Summary of world literature on infrainguinal nonanastomotic aneurysms in autologous vein grafts
Author Patient age Patient sex CV risk factors Indication for graft Graft Years to occurrence
Alexander7 65 Male S,D,H Aneurysm in situ 3
Fukui20 49 Male S Aneurysm in situ 10
Peer21 52 Male S,L Aneurysm RGSV 7
52 Male S,H,L Aneurysm RGSV 8
47 Male S,L Occlusive disease RGSV 3
Bevers15 25 Male Cyclism (?) Occlusive disease RGSV 2/4
Kelly22 81 Male S NA RGSV 22
Barker27 54 Male NA NA RGSV 12
42 Male NA NA RGSV 14/19
Casha23 59 Male None Occlusive disease* RGSV 6
60 Male NA Occlusive disease* in situ 11
De la Rocha24 63 Male NA NA* RGSV 5
DeWeese16 62 Male NA NA RGSV 9
44 Male NA False aneurysm RGSV/RCV 1/1.5
56 Male NA Occlusive disease RGSV 12
Denton25 58 Male S,H NA RGSV 5
63 Male S NA RCV 6
Cloud26 58 Female S,H,L NA RGSV 9
Present 55 Male S Aneurysm in situ 3/7
*Concomitant abdominal aortic aneurysm; CV risk factors, risk factors for cardiovascular diseases; S, smoking; H, hypertension; L, hyper-
lipidemia; RGSV, reversed great saphenous vein graft; RCV, reversed cephalic vein graft; NA, not available.
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prosthetic interposition. In these cases, it is mandato-
ry to follow up the graft throughout the patient’s life.
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